Tonix Pharmaceuticals announced that Dr. Harris presented data on TNX-2900, a product candidate for the treatment of hyperphagia in Prader-Willi syndrome, at a summit.
AI Assistant
TONIX PHARMACEUTICALS HOLDING CORP
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.